NovoCure Limited (NVCR) Earnings History
Annual and quarterly earnings data from 2013 to 2025
Loading earnings history...
NVCR EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
NVCR Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 74.5% | -23.5% | -20.8% |
| 2024 | 77.3% | -28.2% | -27.9% |
| 2023 | 74.8% | -45.7% | -40.6% |
| 2022 | 78.6% | -16.6% | -17.2% |
| 2021 | 78.5% | -8.3% | -10.9% |
Download Data
Export NVCR earnings history in CSV or JSON format
Free sign-in required to download data
NovoCure Limited (NVCR) Earnings Overview
As of May 6, 2026, NovoCure Limited (NVCR) reported trailing twelve-month net income of -$173M, reflecting +21.8% year-over-year growth. The company earned $-1.52 per diluted share over the past four quarters, with a net profit margin of -20.8%.
Looking at the long-term picture, NVCR's historical earnings data spans multiple years. The company achieved its highest annual net income of $20M in fiscal 2020.
NovoCure Limited is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including NKTR (-$121M net income, -297.1% margin), INVA ($271M net income, 63.8% margin), SUPN (-$29M net income, -5.4% margin), NVCR has outperformed on profitability metrics. Compare NVCR vs NKTR →
NVCR Earnings vs Peers
Earnings metrics vs comparable public companies
NVCR Historical Earnings Data (2013–2025)
13 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$136M | +19.2% | -$154M | $-1.22 | -20.8% | -23.5% |
| 2024 | -$169M | +18.6% | -$170M | $-1.56 | -27.9% | -28.2% |
| 2023 | -$207M | -123.7% | -$233M | $-1.95 | -40.6% | -45.7% |
| 2022 | -$93M | -58.6% | -$90M | $-0.88 | -17.2% | -16.6% |
| 2021 | -$58M | -394.6% | -$44M | $-0.56 | -10.9% | -8.3% |
| 2020 | $20M | +374.0% | $30M | $0.18 | 4.0% | 6.1% |
| 2019 | -$7M | +88.6% | $-914,000 | $-0.07 | -2.1% | -0.3% |
| 2018 | -$64M | -3.1% | -$34M | $-0.69 | -25.6% | -13.6% |
| 2017 | -$62M | +53.2% | -$39M | $-0.70 | -34.8% | -22.2% |
| 2016 | -$132M | -18.2% | -$115M | $-1.54 | -159.1% | -139.1% |
See NVCR's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NVCR Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NVCR vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonNVCR — Frequently Asked Questions
Quick answers to the most common questions about buying NVCR stock.
Is NVCR growing earnings?
NVCR EPS is $-1.52, with earnings growth accelerating to +21.8%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-173M.
What are NVCR's profit margins?
NovoCure Limited net margin is -20.8%, with operating margin at -23.5%. Below-average margins reflect competitive or cost pressures.
How consistent are NVCR's earnings?
NVCR earnings data spans 2013-2025. The accelerating earnings trend is +21.8% YoY. Historical data enables comparison across business cycles.